The drug, which Novo Nordisk calls simply the Wegovy pill, uses the same active ingredient - semaglutide - that powers the original Wegovy, along with its sister drug for diabetes, Ozempic
Literature indicates that plasma-free carnitine concentrations return to baseline within 24 h following a single oral dose due to rapid renal clearance and minimal tissue retention in the short term
Importantly, this was not driven by aggressive rebate engineering
GLP-1 provides systemic metabolic benefits: Reduced Visceral Fat: GLP-1 preferentially mobilizes harmful visceral adiposity (fat around organs), which drives inflammation and cardiometabolic disease
By slowing down gastric emptying, it makes individuals feel full longer, reducing their overall food intake
The primary concern at high doses (3g+) is the potential for elevated TMAO levels via gut bacteria conversion, though the clinical significance of this at moderate supplemental doses is debated